Plutonium tricks cells by “pretending” be iron

Plutonium tricks cells by “pretending” to be iron

10:38 AM, 13th July 2011
Plutonium tricks cells by “pretending” to be iron
Researchers learned that, to get into cells, plutonium uses iron as a "trojan horse."

ARGONNE, US: Researchers at the US Department of Energy’s Argonne National Laboratory and Northwestern University have identified a new biological pathway by which plutonium finds its way into mammalian cells. The researchers learned that, to get into cells, plutonium acts like a “Trojan horse,” duping a special membrane protein that is typically responsible for taking up iron.

This discovery may help enhance the safety of workers who deal with plutonium, as well as show the way to new “bio-inspired” approaches for separating radioactive elements from other metals in used nuclear fuel.

The evolving bodies of mammals have no natural ability to recognize plutonium.  Scientists were curious to know the cellular mechanisms responsible for its retention in the body. The researchers exposed adrenal cells from rats to minute quantities of plutonium to see how cells accumulated the radioactive material.

Using high-energy X-rays provided by Argonne’s Advanced Photon Source, the researchers were able to characterize a particular protein known as “transferrin,” which is responsible for bringing iron into cells. Each transferrin is made up of two subunits, known as N and C that normally bind iron. When another protein, recognizes both the N and C subunits, it admits the molecule to the cell. However, when both the N and C subunits contain plutonium, the transferrin receptor doesn’t recognize the protein and keeps it out.

Contrary to their expectations, the researchers discovered that in one of the mixed states - when an iron-containing N-subunit is combined with a plutonium-containing C-subunit, the resulting hybrid so closely resembles the normal iron protein that the uptake pathway is “tricked” into allowing plutonium to enter the cell.

“Although the interaction between plutonium and bodily tissues has been studied for a long time, this is the first conclusive identification of a specific pathway that allows for the introduction of plutonium into cells,” said Mark Jensen, an Argonne Chemist who led the research.

The results of the study were published online on the website of Nature Chemical Biology on June 26. The research was funded by the US Department of Energy’s Office of Science as well as by the National Institutes of Health.

© Argonne National Laboratory News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

DSM acquires 51 per cent stake in AGI Corporation, Taiwan

HEERLEN, THE NETHERLANDS: Royal DSM N V has acquired a 51 per cent stake in AGI Corporation of Taiwan through a subscription for newly to be issued sh ...

Read more
While you are up, print me a solar cell

New MIT-developed materials make it possible to produce photovoltaic cells on paper or fabric, nearly as simply as printing a document. CAMBRIDGE, US ...

Read more
Technip bags Solvay contract for chemical plant in China

PARIS, FRANCE: Technip is awarded an engineering services contract by Solvay in China. This is for the construction of the previously announced epichl ...

Read more
Research shows ‘BPA-free’ bottles live up to manufacturers’ claims

CINCINNATI, US: The alarm caused by bisphenol A (BPA) presence in reusable plastic bottles resulted in a recent industry change, producing products ma ...

Read more
Berkeley researchers apply NMR/MRI to microfluidic chromatography

  BERKELEY, US: By pairing an award-winning remote-detection version of NMR/MRI technology with a unique version of chromatography specifically ...

Read more
MES obtains global sub-license for lithium cathode materials business

TOKYO, JAPAN: Mitsui Engineering & Shipbuilding Co Ltd (MES) has obtained a worldwide non-exclusive sub-license for the manufacture, sale and use ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X